Port Delivery Platform with ranibizumab for treating wet age-related macular degeneration [ID3983]
Awaiting development
Reference number: GID-TA10879
Expected publication date:
The topic was discussed at the Topic Selection Oversight Panel (TSOP) in April 2022. The panel concluded that the topic was suitable for a Technology Appraisal. Following conversations with the company, the scheduling of the evaluation is to be confirmed and stakeholders will be updated in due course.